Overcoming Therapy Resistance in HER2‐positive Breast Cancer with the Dual Rac/Cdc42 Inhibitor MBQ‐167

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2021
Source ID
10.1096/fasebj.2021.35.s1.03931

Entities

People

  • Luis Velazquez‐vega
  • Michael Rivera‐robles
  • Paula Vigo‐morales
  • Suranganie Dharmawardhane

Organizations

  • National Institute of General Medical Sciences
  • National Institutes of Health
  • Puerto Rico Science, Technology and Research Trust
  • United States Department of Defense